These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 2296272)

  • 21. The steatocrit: a simple method for monitoring fat malabsorption in patients with cystic fibrosis.
    Colombo C; Maiavacca R; Ronchi M; Consalvo E; Amoretti M; Giunta A
    J Pediatr Gastroenterol Nutr; 1987; 6(6):926-30. PubMed ID: 3681578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels.
    Rock MJ; Mischler EH; Farrell PM; Wei LJ; Bruns WT; Hassemer DJ; Laessig RH
    Pediatrics; 1990 Jun; 85(6):1001-7. PubMed ID: 2187173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exocrine pancreatic function in cystic fibrosis.
    Guy-Crotte O; Carrère J; Figarella C
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):755-9. PubMed ID: 8864671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany).
    Siret D; Bretaudeau G; Branger B; Dabadie A; Dagorne M; David V; de Braekeleer M; Moisan-Petit V; Picherot G; Rault G; Storni V; Roussey M
    Pediatr Pulmonol; 2003 May; 35(5):342-9. PubMed ID: 12687590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology of the pancreas in cystic fibrosis.
    Durie PR
    Neth J Med; 1992 Oct; 41(3-4):97-100. PubMed ID: 1470291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in the pancreatic and respiratory functions in cystic fibrosis. The influence of the time of the evolution of the disease].
    Ericson N; Navarro S; Valderrama R; Adrián MJ; Lloberes P; Cobos N
    Med Clin (Barc); 1993 Nov; 101(17):650-2. PubMed ID: 8289509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tubeless tests of exocrine pancreatic function in patients with cystic fibrosis.
    Lamers CB
    Neth J Med; 1992 Oct; 41(3-4):101-4. PubMed ID: 1470277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mucoviscidosis screening with immunoreactive trypsin].
    Eber E; Ellemunter H; Engele H; Götz M; Grünberger W; Haas J; Janisch H; Leodolter S; Litscher H; Müller G
    Wien Klin Wochenschr; 1992; 104(22):681-5. PubMed ID: 1475973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency.
    Couper RT; Corey M; Moore DJ; Fisher LJ; Forstner GG; Durie PR
    Pediatr Res; 1992 Aug; 32(2):179-82. PubMed ID: 1508606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of neonatal screening for cystic fibrosis. Evaluation of a neonatal screening program including 34,522 neonates (author's transl)].
    Cristol P; Des Georges M; Levy A; Sahuc P
    Sem Hop; 1982 Feb; 58(8):499-55. PubMed ID: 6278637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Newborn screening for cystic fibrosis, a clinical geneticist perspective].
    Sanak M
    Przegl Lek; 2011; 68(1):14-6. PubMed ID: 21563437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of pancreatic function during the first year in infants with cystic fibrosis.
    O'Sullivan BP; Baker D; Leung KG; Reed G; Baker SS; Borowitz D
    J Pediatr; 2013 Apr; 162(4):808-812.e1. PubMed ID: 23245194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic phenotype in infants with cystic fibrosis identified by mutation screening.
    Cipolli M; Castellani C; Wilcken B; Massie J; McKay K; Gruca M; Tamanini A; Assael MB; Gaskin K
    Arch Dis Child; 2007 Oct; 92(10):842-6. PubMed ID: 17449517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indirect parameters of pancreatic function in cystic fibrosis (CF) during a controlled double-blind trial of pancreatic supplementation.
    Regele S; Henker J; Münch R; Barbier Y; Stern M
    J Pediatr Gastroenterol Nutr; 1996 Jan; 22(1):68-72. PubMed ID: 8788290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step.
    Pollitt RJ; Dalton A; Evans S; Hughes HN; Curtis D
    J Med Screen; 1997; 4(1):23-8. PubMed ID: 9200059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis.
    Bronstein MN; Sokol RJ; Abman SH; Chatfield BA; Hammond KB; Hambidge KM; Stall CD; Accurso FJ
    J Pediatr; 1992 Apr; 120(4 Pt 1):533-40. PubMed ID: 1552390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for cystic fibrosis by a stool trypsin method.
    Forrest DC; Wilcken B; Turner G
    Arch Dis Child; 1981 Feb; 56(2):151-3. PubMed ID: 7469468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystic fibrosis serum pancreatic amylase. Useful discriminator of exocrine function.
    Gillard BK; Cox KL; Pollack PA; Geffner ME
    Am J Dis Child; 1984 Jun; 138(6):577-80. PubMed ID: 6202136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.